Profund Advisors LLC Cuts Stock Position in The Clorox Company (NYSE:CLX)

Profund Advisors LLC lessened its holdings in The Clorox Company (NYSE:CLX) by 5.6% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 1,890 shares of the company’s stock after selling 113 shares during the period. Profund Advisors LLC’s holdings in The Clorox were worth $338,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the business. Bank of New York Mellon Corp increased its stake in The Clorox by 4.8% in the 1st quarter. Bank of New York Mellon Corp now owns 1,551,035 shares of the company’s stock worth $299,164,000 after buying an additional 70,987 shares in the last quarter. Champlain Investment Partners LLC increased its stake in The Clorox by 34.3% in the 2nd quarter. Champlain Investment Partners LLC now owns 1,395,525 shares of the company’s stock worth $251,069,000 after buying an additional 356,260 shares in the last quarter. Stifel Financial Corp increased its stake in The Clorox by 4.1% in the 1st quarter. Stifel Financial Corp now owns 1,133,754 shares of the company’s stock worth $218,684,000 after buying an additional 44,189 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in The Clorox by 9.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,123,966 shares of the company’s stock worth $216,791,000 after buying an additional 96,332 shares in the last quarter. Finally, Nuveen Asset Management LLC increased its stake in The Clorox by 24.4% in the 1st quarter. Nuveen Asset Management LLC now owns 1,017,623 shares of the company’s stock worth $196,280,000 after buying an additional 199,542 shares in the last quarter. Institutional investors and hedge funds own 77.77% of the company’s stock.

Shares of NYSE CLX opened at $160.73 on Thursday. The company has a debt-to-equity ratio of 4.20, a current ratio of 0.89 and a quick ratio of 0.52. The company has a market cap of $19.74 billion, a P/E ratio of 29.01, a PEG ratio of 4.37 and a beta of 0.21. The Clorox Company has a 1 year low of $159.32 and a 1 year high of $231.11. The firm has a 50-day simple moving average of $166.55 and a two-hundred day simple moving average of $176.86.

The Clorox (NYSE:CLX) last announced its quarterly earnings data on Tuesday, August 3rd. The company reported $0.95 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.29 by ($0.34). The firm had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.91 billion. The Clorox had a return on equity of 94.42% and a net margin of 9.67%. The firm’s revenue for the quarter was down 9.1% on a year-over-year basis. During the same period in the previous year, the business earned $2.41 EPS. As a group, equities research analysts expect that The Clorox Company will post 5.54 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 10th. Shareholders of record on Wednesday, October 27th will be paid a $1.16 dividend. This represents a $4.64 annualized dividend and a yield of 2.89%. The ex-dividend date is Tuesday, October 26th. The Clorox’s payout ratio is currently 64.00%.

CLX has been the subject of a number of research analyst reports. Argus lowered The Clorox from a “buy” rating to a “hold” rating in a research report on Friday, September 3rd. Credit Suisse Group cut their price objective on The Clorox from $175.00 to $160.00 and set a “neutral” rating for the company in a research report on Wednesday, August 4th. UBS Group cut their price objective on The Clorox from $166.00 to $154.00 and set a “sell” rating for the company in a research report on Wednesday, August 4th. They noted that the move was a valuation call. Royal Bank of Canada cut their price objective on The Clorox from $200.00 to $176.00 and set a “sector perform” rating for the company in a research report on Wednesday, August 4th. Finally, Wells Fargo & Company cut their price objective on The Clorox from $170.00 to $155.00 and set an “underweight” rating for the company in a research report on Wednesday, August 4th. Five analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, The Clorox has a consensus rating of “Hold” and an average price target of $182.11.

The Clorox Profile

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Cleaning, Lifestyle, Household, and International. The Cleaning segment consists of laundry, home care, and professional products marketed and sold in the United States.

Read More: What are earnings reports?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX).

Institutional Ownership by Quarter for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.